JSW Infrastructure IPO vs Valiant Laboratories IPO

Comparison between JSW Infrastructure IPO and Valiant Laboratories IPO.

IPO Details

JSW Infrastructure IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Valiant Laboratories IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of JSW Infrastructure IPO is up to ₹2,800.00 Cr whereas the issue size of the Valiant Laboratories IPO is up to ₹152.46 Cr. The final issue price of JSW Infrastructure IPO is ₹119.00 per share and of Valiant Laboratories IPO is ₹140.00 per share.

 JSW Infrastructure IPOValiant Laboratories IPO
Face Value₹2 per share₹10 per share
Issue Price (Lower)₹113.00 per share₹133.00 per share
Issue Price (Upper)₹119.00 per share₹140.00 per share
Issue Price (Final)₹119.00 per share₹140.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)
Market Lot Size126 shares105 shares
Fresh Issue Size23,52,94,117 shares1,08,90,000 shares
Fresh Issue Size (Amount)up to ₹2,800.00 Crup to ₹152.46 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total23,52,94,117 shares1,08,90,000 shares
Issue Size Total (Amount)up to ₹2,800.00 Crup to ₹152.46 Cr

IPO Timetable

JSW Infrastructure IPO opens on Sep 25, 2023, while Valiant Laboratories IPO opens on Sep 27, 2023. The closing date of JSW Infrastructure IPO and Valiant Laboratories IPO is Sep 27, 2023, and Oct 03, 2023, respectively.

 JSW Infrastructure IPOValiant Laboratories IPO
Anchor Bid DateSep 22, 2023Sep 26, 2023
Issue OpenSep 25, 2023Sep 27, 2023
Issue CloseSep 27, 2023Oct 03, 2023
Basis Of Allotment (Tentative)Sep 28, 2023Oct 05, 2023
Initiation of Refunds (Tentative)Sep 28, 2023Oct 06, 2023
Credit of Share (Tentative)Sep 29, 2023Oct 06, 2023
Listing date (Tentative)Oct 03, 2023Oct 06, 2023
Anchor Lockin End date 1Oct 28, 2023Nov 04, 2023
Anchor Lockin End date 2Dec 27, 2023Jan 03, 2024

Financials & KPIs

JSW Infrastructure IPO P/E ratio is 29.67, as compared to Valiant Laboratories IPO P/E ratio of 15.71.

 JSW Infrastructure IPOValiant Laboratories IPO
Financials

Company Financials (Restated Consolidated)

Period Ended31 Mar 202331 Mar 202231 Mar 202131 Mar 2020
Assets9,450.669,429.468,254.557,191.85
Total Income3,372.852,378.741,678.261,237.37
Profit After Tax749.51330.44284.62196.53
NET Worth3,934.643,212.132,831.182,488.23
Reserves and Surplus3,645.753,208.982,829.842,486.53
Total Borrowing4,243.704,408.693,945.823,102.57
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets212.76181.81106.31
Total Income338.77293.47183.78
Profit After Tax29.0027.5030.59
NET Worth100.4971.4688.58
Total Borrowing59.4060.680.35
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)96.42100.00
Promoter Shareholding (Post-Issue)85.6174.94
P/E Ratio29.6715.71
Market Cap₹24990.00 Cr.₹608.30 Cr.
ROE18.33%33.73%
ROCE19.49%22.76%
Debt/Equity0.59
EPS₹4.12₹8.91
RoNW18.80%28.86%

Shares Offered

In the JSW Infrastructure IPO Retail Individual Investors (RII) are offered 2,35,29,411 shares while in Valiant Laboratories IPO retail investors are offered 2,35,29,411 shares. Qualified Institutional Buyers (QIB) are offered 7,05,88,237 shares in JSW Infrastructure IPO and 21,78,030 shares in Valiant Laboratories IPO.

 JSW Infrastructure IPOValiant Laboratories IPO
Anchor Investor Reservation10,58,82,352 shares32,66,970 shares
Market Maker Reservation
QIB7,05,88,237 shares21,78,030 shares
NII3,52,94,117 shares16,33,500 shares
RII2,35,29,411 shares38,11,500 shares
Employee
Others
Total23,52,94,117 shares1,08,90,000 shares

Bids Received (Subscription)

JSW Infrastructure IPO subscribed 39.36x in total, whereas Valiant Laboratories IPO subscribed 29.76x.

 JSW Infrastructure IPOValiant Laboratories IPO
QIB (times)60.12x20.83x
NII (times)16.83x73.64x
Big NII (times)17.94x78.64x
Small NII (times)14.62x63.64x
RII (times)10.87x16.06x
Employee (times)
Other (times)
Total (times)39.36x29.76x

Compare with others

Compare:

JSW Infrastructure IPO Vs Valiant Laboratories IPO